The U.S. Food and Drug Administration (FDA) has launched a new initiative to address safety problems associated with external infusion pumps and is seeking to establish additional premarket requirements to reduce risks of the devices. “It is time for a more comprehensive approach than we’ve taken to date,” stated Jeffrey Shuren, MD, director of FDA’s…
Are you a Member of NAHC?
Become a member or sign in and read full NAHC Report articles at your leisure. Membership is affordable even if you're a small business and it comes with a lot of other benefits.